Why in news?
A joint study by the LV Prasad Eye Institute in Hyderabad and the Royal Victorian Eye and Ear Hospital in Melbourne, reported on 12 October 2025, found that the severity of keratoconus before treatment predicts the risk of disease progression after collagen cross‑linking (CXL).
Background
Keratoconus is a progressive eye disorder in which the normally round cornea becomes thin and bulges outward into a cone‑like shape. This irregularity causes blurred and distorted vision and typically begins in the teenage years. Collagen cross‑linking is a procedure that uses ultraviolet light and vitamin B2 drops to strengthen corneal tissue and slow or halt the progression of keratoconus.
Key findings of the study
- Severity matters: Patients whose corneas were very steep or thin before undergoing CXL were more likely to experience further progression of keratoconus.
- Need for follow‑up: Some patients required a second CXL procedure because the disease continued to advance despite initial treatment.
- Transplant as last resort: In severe cases where repeated cross‑linking failed, patients needed corneal transplantation to restore vision.
Implications
The findings highlight the importance of early detection and regular monitoring. Doctors may need to adjust follow‑up intervals based on the initial severity of the disease and counsel patients about the possibility of additional procedures. Public awareness of keratoconus symptoms—blurred vision, frequent changes in eyeglass prescriptions and sensitivity to light—can help ensure timely diagnosis.
Source: The Times of India